The Deal
Monday, December 28, 
7:12 pm

Dow Chem going public with Rohm integration story

Posted on November 11, 2009 at 4:17 PM
Filed under: Corporate Strategy | Divesting and Restructuring | Integration
Tagged: ,
[ Share ]  [ E-mail ]  [ Leave a Comment ]
It has been a turbulent year for Dow Chemical Co. (NYSE:DOW). The new year saw the company's Kuwaiti partner pull out of a proposed joint venture, which in turn threw into doubt Dow's planned $16.3 billion purchase of Rohm and Haas Co. Lawsuits and negotiations followed, with Dow finally closing a deal months late in April by leveraging itself up to its gills.

In the months since, Dow has been paying down its debt and integrating what it bought. And the company is now ready to brag about it. The Midland, Mich.-based firm is inviting analysts and press to a day-long event in New York City Thursday to show "how we are applying the power of Dow science and technology to develop innovative solutions to address some of the most pressing issues facing the world today."

The event features remarks by CEO Andrew Liveris and a walk through more than two dozen exhibits on renewable energy production, clean water, increased farm productivity, next-gen batteries and zero-odor paints. While the exhibits represent a wide range of Dow activities, some of the products are the direct result of the Rohm deal.

The highly public exhibit is a sign that Dow, which was in the news for all the wrong reasons last winter as it scrambled to figure out how to buy Rohm, is now seeking out the spotlight. The company said last month a series of divestitures and new financings has allowed it to fully pay off a $9.2 billion bridge loan used to buy Rohm, taking some of the pressure off its balance sheet.

Wall Street has noticed. The company's shares traded Wednesday afternoon at $26.67 apiece, up substantially from a 52-week low of $5.89 hit back in March as fear over the amount of debt the company was taking on to buy Rohm was at its peak.

UBS (NYSE:UBS) analyst Don Carson in a note previewing Thursday's investor day says Dow's "performance businesses are benefiting from cost synergies with the acquired [Rohm] businesses, which translates into high incremental margins as volumes recover." He estimates that synergies from combining the two companies' strengths could contribute up to one-third of earnings per share once Rohm is fully integrated. - Lou Whiteman

Lou Whiteman is a senior writer covering the automotive, transportation and industrial sectors. Follow him on Twitter @louwhiteman




Join Corporate Dealmaker's LinkedIn forum

Comments
Post a comment


Search


Search For

Corporate Dealmaker Video


Deal Economy 2010: Centerview's Effron on large deals

Centerview Partners' Effron on the return of large deals.
Decade of The Deal


Movers & Shakers


Adele Gulfo
Pfizer Inc.

Juergen Lasowski
Onyx Pharmaceuticals Inc.

Edward Swallow
Northrop Grumman Corp.

Owen Mahoney
Outspark

Alice Kim
FLO TV Inc.
Adele Gulfo, Pfizer Inc.
Juergen Lasowski, Onyx Pharmaceuticals Inc.
Edward Swallow, Northrop Grumman Corp.
Owen Mahoney, Outspark
Alice Kim, FLO TV Inc.


COMPLETE MOVERS & SHAKERS ARCHIVES

The Magazine


MACDdec1cover.gifAnd the winners are...
Even in a period when things like toxic credit default swaps and noxious structured investment vehicles dominate the conversation in many parts of the deal community, people are still willing to take the time to recognize skill and achievement in the strategic transactions that help those companies adapt and grow.
View the complete issue


Last Issue
Archives
Suggest a topic
Purchase a reprint
Subscribe to The Deal


Monthly Archives


Syndicate

Contributors

footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.